OBJECTIVE To report the management of a rare case of ovarian hyperstimulation syndrome (OHSS) induced by tamoxifen therapy for breast cancer in a 50-year-old woman. DESIGN Case report. SETTING Gynecology outpatient department of a university hospital. PATIENT(S) A 50-year-old premenopausal patient with a history of breast cancer was prescribed adjuvant treatment with tamoxifen. INTERVEN...

An ovarian hyperstimulation syndrome (OHSS) in spontaneous pregnancies is a very rare event. Hence, clinicians might make wrong decisions, such as laparotomy, because of suspicion of an ovarian carcinoma, or severe complications such as renal insufficiency may develop because the diagnosis and treatment of OHSS are delayed. Here we report a case of a woman in the 15th week of gestation, present...

Ovarian hyperstimulation syndrome (OHSS) is an important complication of ovarian stimulation and IVF that enhances patients' morbidity. To evaluate any increased incidence of hospitalization from severe OHSS during 2000, this study analysed certain clinical, ultrasound and laboratory characteristics of hospitalized patients with severe OHSS. These studies were carried out on women undergoing IV...

Ovarian mutilating surgery is not an option in the management of ovarian hyperstimulation syndrome (OHSS), except in cases with evident tissue necrosis after torsion. When severe OHSS occurs, preservation of fertility must be the target. Therefore, conservative management should be the only feasible approach, as recommended in literature worldwide. Individualization of controlled ovarian hypers...

OHSS is self‐limiting, and treatment is primarily supportive with an aim to reduce the incidence of associated complications. The complications of severe OHSS include renal failure, hypovolemic shock, venous thromboembolism, respiratory distress syndrome, and even death. A particularly severe feature of OHSS is thromboembolism, for which a prevalence of 0.78%, has been reported and which accoun...

Sir, Ovarian hyperstimulation syndrome (OHSS) is a pure iatrogenic complication of assisted reproduction technique (ART), affecting young healthy women seeking fertility. According to a WHO report (Hugues, 2001) this syndrome is responsible to 1 death for every 50 000 treatment cycles, whereas the incidence of severe OHSS is 1%. I assume we all agree that we must thrive to ensure patient safety...

Abstract Background Blood coagulation has been associated with ovulation and female infertility. In this study, the expression of tissue factor system was examined during in immature rats; correlation between ovarian hyperstimulation syndrome (OHSS) evaluated both rats human follicular fluids. Methods Ovaries were obtained at various times after chorionic gonadotropin (hCG) injection to investi...

Background: To explore possible predictors of severe late ovarian hyperstimulation syndrome (SL-OHSS) in fresh embryo transfer cycles. Methods: We conducted a historical cohort study Chinese tertiary hospital from January 2017 to December 2019, with total 6931 women who had the first included. SL-OHSS was defined as symptoms OHSS occurring 12–17 days after ovulation triggering. Possible determi...

Consequences of stimulation of the ovaries include the serious and potentially life-threatening condition of ovarian hyperstimulation syndrome (OHSS). This can occur with any type of ovulation induction or superovulation therapy for assisted conception procedures. The development of OHSS can be reduced by the cautious use of preparations, careful monitoring of stimulation cycles, and prediction...

BACKGROUND Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of IVF/ICSI therapy. The pathophysiology and etiology of the disease is still not fully clarified. METHODS To assess whether polymorphisms of the VEGF/VEGF-receptor system contribute to the occurrence of ovarian hyperstimulation syndrome (OHSS), we performed a retrospective analysis of 116 OHSS patients, and ...